The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Sacha Gnjatic

Ludwig Institute for Cancer Research

Memorial Sloan-Kettering Cancer Center

New York

USA

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, USA. 2002 - 2010

References

  1. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. Gnjatic, S., Cao, Y., Reichelt, U., Yekebas, E.F., Nölker, C., Marx, A.H., Erbersdobler, A., Nishikawa, H., Hildebrandt, Y., Bartels, K., Horn, C., Stahl, T., Gout, I., Filonenko, V., Ling, K.L., Cerundolo, V., Luetkens, T., Ritter, G., Friedrichs, K., Leuwer, R., Hegewisch-Becker, S., Izbicki, J.R., Bokemeyer, C., Old, L.J., Atanackovic, D. Int. J. Cancer (2010) [Pubmed]
  2. Seromic profiling of ovarian and pancreatic cancer. Gnjatic, S., Ritter, E., Büchler, M.W., Giese, N.A., Brors, B., Frei, C., Murray, A., Halama, N., Zörnig, I., Chen, Y.T., Andrews, C., Ritter, G., Old, L.J., Odunsi, K., Jäger, D. Proc. Natl. Acad. Sci. U.S.A. (2010) [Pubmed]
  3. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. Gnjatic, S., Wheeler, C., Ebner, M., Ritter, E., Murray, A., Altorki, N.K., Ferrara, C.A., Hepburne-Scott, H., Joyce, S., Koopman, J., McAndrew, M.B., Workman, N., Ritter, G., Fallon, R., Old, L.J. J. Immunol. Methods (2009) [Pubmed]
  4. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs. Gnjatic, S., Atanackovic, D., Matsuo, M., Jäger, E., Lee, S.Y., Valmori, D., Chen, Y.T., Ritter, G., Knuth, A., Old, L.J. J. Immunol. (2003) [Pubmed]
  5. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Gnjatic, S., Atanackovic, D., Jäger, E., Matsuo, M., Selvakumar, A., Altorki, N.K., Maki, R.G., Dupont, B., Ritter, G., Chen, Y.T., Knuth, A., Old, L.J. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  6. CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Gnjatic, S., Jäger, E., Chen, W., Altorki, N.K., Matsuo, M., Lee, S.Y., Chen, Q., Nagata, Y., Atanackovic, D., Chen, Y.T., Ritter, G., Cebon, J., Knuth, A., Old, L.J. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
 
WikiGenes - Universities